{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T04:34:14Z","timestamp":1774154054830,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>As frequent changes in anti-hypertensive (HTN) medications may reduce adherence to the treatments, identifying modifiable factors leading to changes in anti-HTN medications can help clinicians optimize treatment strategies for individual patients. We performed this study to explore the pattern of anti-HTN medications and to identify factors that are associated with the changes in anti-HTN medications. To this end, we used a clinical database of Seoul National University Hospital, extracted, transformed, and loaded by the observational medical outcomes partnership common data model. Demographic and all recorded clinical diagnoses, medications, and procedures data of eligible subjects were collected. Of 636 subjects who were eligible for this study, 297 subjects with a record of \u22651 anti-HTN medication changes and other 297 subjects without a record of medication change were selected for the study population. High diastolic blood pressure (adjusted odds ratio [OR]: 1.02, 95% confidence interval [CI]: 1.001\u20131.040, <jats:italic>p<\/jats:italic> = 0.040), arrhythmia (adjusted OR: 10.01, 95% CI: 1.86\u2013185.57, <jats:italic>p<\/jats:italic> = 0.030), and angina pectoris with antianginal agents (adjusted OR: 4.85, CI: 1.05\u201323.89, <jats:italic>p<\/jats:italic> = 0.046) were associated with the changes in anti-HTN medications, indicating that any patients with these covariates require additional attention to reduce the likelihood of changing anti-HTN medications.<\/jats:p>","DOI":"10.3389\/fcvm.2022.999548","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T06:57:29Z","timestamp":1664521049000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Factors affecting the changes in antihypertensive medications in patients with hypertension"],"prefix":"10.3389","volume":"9","author":[{"given":"Tae Kyu","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoomin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YeSol","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyeon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Sik","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","article-title":"Hypertension and cardiovascular risk: general aspects","volume":"129","author":"Kjeldsen","year":"2018","journal-title":"Pharmacol Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/HYPERTENSIONAHA.119.13437","article-title":"Future of hypertension","volume":"74","author":"Dzau","year":"2019","journal-title":"Hypertension."},{"key":"B3","unstructured":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ajh.2010.172","article-title":"Obesity-related hypertension: epidemiology, pathophysiology, and clinical management","volume":"23","author":"Kotchen","year":"2010","journal-title":"Am J Hypertens."},{"key":"B5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1524-6175.2007.07152.x","article-title":"Hypertension management: results of a new national survey for the hypertension education foundation: harris interactive","volume":"9","author":"Moser","year":"2007","journal-title":"J Clin Hyperten."},{"key":"B6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/HJH.0000000000002294","article-title":"Medication adherence in hypertension","volume":"38","author":"Poulter","year":"2020","journal-title":"J Hypertens."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e17825","DOI":"10.1097\/MD.0000000000017825","article-title":"Impact of number of medications and age on adherence to antihypertensive medications: a nationwide population-based study","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.amjmed.2006.06.028","article-title":"Antihypertensive medication adherence in the department of veterans affairs","volume":"120","author":"Siegel","year":"2007","journal-title":"Am J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/BOR.0b013e32832c6aa4","article-title":"Adherence to osteoporosis treatments: room for improvement","volume":"21","author":"Warriner","year":"2009","journal-title":"Curr Opin Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/qjmed\/hcz058","article-title":"Medication adherence among patients with chronic diseases: a survey-based study in pharmacies","volume":"112","author":"Jungst","year":"2019","journal-title":"QJM."},{"key":"B11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ajh.2009.95","article-title":"Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients","volume":"22","author":"Wong","year":"2009","journal-title":"Am J Hypertens."},{"key":"B12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/hr.2011.43","article-title":"Profiles of discontinuation and switching of thiazide diuretics: a cohort study among 9398 Chinese hypertensive patients","volume":"34","author":"Wong","year":"2011","journal-title":"Hypertens Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ajh.2009.67","article-title":"Factors associated with antihypertensive drug discontinuation among Chinese patients: a cohort study","volume":"22","author":"Wong","year":"2009","journal-title":"Am J Hypertens."},{"key":"B14","unstructured":"InformaticsOHDSa,. 2020 Data Network.\n          2021"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7329","DOI":"10.1073\/pnas.1510502113","article-title":"Characterizing treatment pathways at scale using the OHDSI network","volume":"113","author":"Hripcsak","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.12997\/jla.2019.8.2.78","article-title":"2018 Guidelines for the management of dyslipidemia in Korea","volume":"8","author":"Rhee","year":"2019","journal-title":"J Lipid Atheroscler."},{"key":"B17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4168\/aair.2020.12.3.430","article-title":"Evaluation of Drug-Induced Liver Injury Developed During Hospitalization Using Electronic Health Record (EHR)-Based Algorithm","volume":"12","author":"Kang","year":"2020","journal-title":"Allergy Asthma Immunol Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4070\/kcj.2016.46.3.275","article-title":"2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)","volume":"46","year":"2016","journal-title":"Korean Circ J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Kidney","year":"2021","journal-title":"Kidney Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40885-019-0124-x","article-title":"2018 Korean society of hypertension guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension","volume":"25","author":"Lee","year":"2019","journal-title":"Clin Hypertens."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4842-2334-5_4","article-title":"Data visualization in R","author":"Ramasubramanian","year":""},{"key":"B22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.21037\/atm.2016.03.35","article-title":"Variable selection with stepwise and best subset approaches","volume":"4","author":"Zhang","year":"2016","journal-title":"Ann Transl Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1155\/2019\/4735876","article-title":"Prescribing patterns of antihypertensives for treatment-na\u00efve patients in South Korea: from Korean NHISS claim data","author":"Kim","year":"2019"},{"key":"B24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2147\/CLEP.S265966","article-title":"Comprehensive trends and patterns of antihypertensive prescriptions using a nationwide claims database in Korea","volume":"12","author":"Jung","year":"2020","journal-title":"Clin Epidemiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41440-022-00890-8","article-title":"Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database","volume":"45","author":"Kim","year":"2022","journal-title":"Hypertens Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/bmj.322.7291.912","volume":"322","year":"2001","journal-title":"BMJ."},{"key":"B27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/JAHA.117.006986","article-title":"Combination therapy is superior to sequential monotherapy for the initial treatment of hypertension: a double-blind randomized controlled trial","author":"MacDonald","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/2050-6511-14-39","article-title":"The association between prescription change frequency, chronic disease score and hospital admissions: a case control study","volume":"14","author":"Sino","year":"2013","journal-title":"BMC Pharmacol Toxicol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s11096-021-01252-z","article-title":"Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study","volume":"43","author":"Lee","year":"2021","journal-title":"Int J Clin Pharm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11886-015-0662-0","article-title":"Management of hypertension in patients with ischemic heart disease","volume":"17","author":"Agbor-Etang","year":"2015","journal-title":"Curr Cardiol Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10557-016-6682-1","article-title":"Beta-blockers and calcium channel blockers: first line agents","volume":"30","author":"Pascual","year":"2016","journal-title":"Cardiovasc Drugs Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0266911","DOI":"10.1371\/journal.pone.0266911","article-title":"Extract, transform, load framework for the conversion of health databases to OMOP","volume":"17","author":"Quiroz","year":"2022","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s10916-018-1076-5","article-title":"Analysis of treatment pathways for three chronic diseases using OMOP CDM","volume":"42","author":"Zhang","year":"2018","journal-title":"J Med Syst."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40885-020-00151-1","article-title":"Treatment adherence among patients with hypertension: findings from a cross-sectional study","volume":"26","author":"Algabbani","year":"2020","journal-title":"Clin Hypertens."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.999548\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T06:57:36Z","timestamp":1664521056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.999548\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2022.999548"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.999548","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"article-number":"999548"}}